Proof-of-concept study holds promise for safer gene therapy techniques for treating immunodeficiencies Post author: Post published:November 1, 2023 Post category:uncategorized Researchers described an approach to edit the recombination-activating gene 2 (RAG2) locus for therapeutic applications. You Might Also Like Ultrasensitive ctDNA detection improves risk prediction in early-stage lung cancer January 15, 2025 Weekly injections of anti-obesity medications cost more than surgery October 7, 2024 Study reveals common yet overlooked mystical experiences impact well-being May 26, 2024